Monthly Archives: June 2013

Piedmont Pharmaceuticals Gains FDA Approval of Animal Health Soft Chew Pain Medication

Greensboro, NC, June 20, 2013 – Last week the US Food and Drug Administration’s Center for Veterinary Medicine approved the first application of Piedmont Pharmaceuticals’ invention of a canine soft chew formulation containing a veterinary medicine.  This flavored soft chew formulation contains carprofen and is labeled for the relief of pain and inflammation from osteoarthritis and the control of post-operative pain in dogs. It is the first and only flavored, soft and chewable medicine in the pain category.

The soft chew formulation will provide pet owners with a convenient and friendly way to medicate dogs.  According to Roland Johnson, Chairman and CEO of Piedmont Pharmaceuticals, “The veterinary pharmaceutical industry has been working on a soft chew formulation for the past two decades and we are proud, following a relatively short development timeline, to have successfully registered this highly palatable, wonderfully textured product to positively impact the medicating experience for both dogs and their owners.” In addition Johnson noted that, “this formulation has been issued multiple US patents in the past two years.”

Osteoarthritis is a problem for dogs as they get older, particularly for larger breeds.  A common sign that owners will notice in their dog is difficulty climbing stairs or jumping into the back of a car. Pain is the third largest veterinary treatment category in companion animal health.

About Piedmont Pharmaceuticals

Piedmont Pharmaceuticals is a company that develops FDA and EPA regulated products for animals, emphasizing dogs and cats. In addition, their pipeline includes livestock products along with a group of technology-related human products.

Media Contact: Jackie Plemmons, Tel. 336-544-0320

North Carolina Angel Groups Host Angel Capital Association’s Southeast Regional Meeting

DURHAM, NC, June 5, 2013 — The Angel Capital Association (ACA) has announced that the annual Southeast Regional meeting will be held at the Raleigh Convention Center in Raleigh, NC on September 16 and 17, 2013. It will be hosted by North Carolina angel investor groups RTP Capital Associates, Triangle Angel Partners (TAP), Piedmont Angel Network, Inception Micro Angel Fund, Investors’ Circle and Wilmington Investors Network, with organizational help from CED.

“This is one of the best opportunities for accredited investors interested in early stage companies to network with their peers in the Southeast,” said Elaine Bolle, president of the Board of Directors, RTP Capital Associates. “The conference provides a forum to share ideas and deals, and to discuss current issues that matter to angel investors.”

The meeting brings early stage investors from the Southeast closer together, promoting best practices and deal syndication. Speakers include Burr Sutter, senior product manager for Red Hat/JBoss, and Bob Okabe, managing director, RPX Group LLC, who will lead the Angel Resource Institute workshop Trends in Raising Capital, featuring updated industry data. Other speakers will be announced soon and listed on the website. On Tuesday, September 17, there will be a showcase of over 30 early stage companies. An investor-only dinner follows the second day.

“North Carolina’s entrepreneurial community wins when angel investors gather in the Research Triangle,” said Joan Siefert Rose, President of CED. The meeting coincides with the CED Tech Venture Conference, offering greater incentives for the investors to identify new deal flow opportunities from some of the brightest early stage companies in the region.

Registration for both the ACA Southeast Regional meeting and the CED Tech Venture Conference is $225; attendees who cannot stay for the Tech Venture Conference will pay $175. The highly discounted ‘bundled event’ fee allows investors to extend their stay and see the Triangle’s hottest early stage start-ups.

About ACA

The Angel Capital Association is the leading professional and trade association supporting the success of angel investors in high-growth, early-stage ventures. More information on ACA’s activities and its growing network of over 200 angel groups may be found at

About CED

CED’s mission is to identify, enable and promote high-growth, high-impact companies and to accelerate the entrepreneurial culture of the Research Triangle and North Carolina.

About the Angel Groups Participating

RTP Capital Associates is a member-driven angel network giving insight, guidance, and other strategic resources while investing in seed and early-stage companies primarily in the Southeastern US.

Triangle Angel Partners (TAP) is an experienced band of angels in the high tech and life sciences industries with $3 million in committed capital, interested in investing their time, analysis and money into early life cycle companies.

The Piedmont Angel Network operates a series of committed capital funds and has invested more than $10 million in 23 start-up companies since 2002.

IMAF-RTP is a member managed angel seed fund that is organized to provide members an opportunity for active involvement in a diversified capital investment process.

Investors’ Circle is the oldest, largest, and most successful early stage impact investing network, with $172 million invested in enterprises solving significant social or environmental challenges.

Wilmington Investor’s Network is a network fund of early stage investors with investments in technology and biotechnology and partners with other angel funds and networks throughout the United States.